Jiang Junjie, Shen Hao, Zhang Yi, Li Yuanyuan, Jing Yuanyuan, Chen Xinyi, Wu Hongli, Xie Yanming, Liu Huan
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Front Neurol. 2024 Oct 2;15:1420510. doi: 10.3389/fneur.2024.1420510. eCollection 2024.
OBJECTIVE: The study attempted to evaluate the meta-analyses (MAs) of the acupuncture treatment of diabetic peripheral neuropathy (DPN) to provide a basis for clinical decision-making. METHODS: Eight databases, such as PubMed, Cochrane Library, Embase, Web of Science, CNKI, Wanfang Data, CQVIP, and CBM, were searched from database creation to December 22, 2023. The MAs of DPN treatment using acupuncture or acupuncture combined with conventional Western medicine were included. AMSTAR-2 and PRISMA 2020 helped evaluate the methodological and reporting quality of the included studies. The GRADE methodology helped assess the evidence quality of outcome indicators. Evidence mapping was performed to display evaluation results. RESULTS: A total of 18 MAs involving 23,240 DPN patients were included. Based on the methodological quality evaluation, four MAs were of "moderate" quality, seven had a quality grade of "low," and another seven were of "critically low" quality. The evidence quality evaluation showed that among studies of acupuncture vs. conventional Western medicine, four had an evidence quality of "moderate," 18 had an evidence quality of "low," and 17 had an evidence quality of "critically low" and that among studies of acupuncture + conventional Western medicine vs. conventional Western medicine, 12 had an evidence quality of "moderate," 29 had an evidence quality of "low," and 33 had an evidence quality of "critically low." Compared with conventional Western medicine, simple acupuncture and acupuncture + conventional Western medicine significantly improved total effective rate (TER) and nerve conduction velocity (NCV). CONCLUSION: Acupuncture treatment of DPN significantly improves TER and NCV with proven safety. However, the MAs of the acupuncture treatment of DPN must strictly refer to relevant standards and specifications regarding methodological and reporting quality, along with the design, execution, and reporting of primary randomized controlled trials (RCTs).
目的:本研究旨在评估针刺治疗糖尿病周围神经病变(DPN)的Meta分析,为临床决策提供依据。 方法:检索了8个数据库,包括PubMed、Cochrane图书馆、Embase、Web of Science、中国知网、万方数据、维普资讯和中国生物医学文献数据库,检索时间从数据库创建至2023年12月22日。纳入针刺或针刺联合西医常规治疗DPN的Meta分析。使用AMSTAR-2和PRISMA 2020评估纳入研究的方法学和报告质量。采用GRADE方法评估结局指标的证据质量。进行证据映射以展示评估结果。 结果:共纳入18项Meta分析,涉及23240例DPN患者。基于方法学质量评估,4项Meta分析为“中等”质量,7项质量等级为“低”,另外7项为“极低”质量。证据质量评估显示,在针刺与西医常规治疗的研究中,4项证据质量为“中等”,18项为“低”,17项为“极低”;在针刺联合西医常规治疗与西医常规治疗的研究中,12项证据质量为“中等”,29项为“低”,33项为“极低”。与西医常规治疗相比,单纯针刺和针刺联合西医常规治疗显著提高了总有效率(TER)和神经传导速度(NCV)。 结论:针刺治疗DPN可显著提高TER和NCV,且安全性已得到证实。然而,针刺治疗DPN的Meta分析必须严格参照有关方法学和报告质量以及初级随机对照试验(RCT)设计、实施和报告的相关标准和规范。
J Clin Pharm Ther. 2021-6
Complement Ther Med. 2024-3
Chin J Integr Med. 2021-12
Medicine (Baltimore). 2021-4-9
Front Med (Lausanne). 2023-7-31
Medicine (Baltimore). 2025-6-6
Front Neurol. 2023-11-16
Int J Biostat. 2023-3-27
Ann Palliat Med. 2023-3
Front Endocrinol (Lausanne). 2022
Syst Rev. 2022-9-5
Biomed Pharmacother. 2022-4